Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,656 | 34,551 | 35,617 | 96,494 | 22,465 |
| Marketable Securities | 171,301 | 223,818 | 274,347 | 259,104 | 147,561 |
| Receivables | 3,473 | 2,895 | 2,620 | 1,526 | 1,010 |
| Inventories | 231 | 636 | 585 | 514 | 381 |
| TOTAL | $246,193 | $268,606 | $320,844 | $364,647 | $176,547 |
| Non-Current Assets | |||||
| PPE Net | 2,484 | 2,135 | 1,954 | 1,843 | 1,987 |
| Intangibles | 44,543 | 44,543 | 44,543 | 44,543 | 44,543 |
| Other Non-Current Assets | 5,200 | 5,839 | 6,015 | 6,186 | 6,352 |
| TOTAL | $52,227 | $52,517 | $52,512 | $52,572 | $52,882 |
| Total Assets | $298,420 | $321,123 | $373,356 | $417,219 | $229,429 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,801 | 14,201 | 12,220 | 8,067 | 14,389 |
| Accrued Expenses | 30,447 | 21,845 | 15,656 | 15,332 | 17,157 |
| TOTAL | $45,248 | $36,046 | $27,876 | $23,399 | $31,546 |
| Non-Current Liabilities | |||||
| Long Term Debt | 100,298 | 99,895 | 99,499 | 99,874 | 99,508 |
| Other Non-Current Liabilities | 6,924 | 6,670 | 6,001 | 5,079 | 5,265 |
| TOTAL | $107,222 | $106,565 | $105,500 | $104,953 | $104,773 |
| Total Liabilities | $152,470 | $142,611 | $133,376 | $128,352 | $136,319 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 361,492 | 361,492 | 361,492 | 246,237 | 246,237 |
| Common Shares | 363 | 363 | 363 | 248 | 245 |
| Retained earnings | -1,967,242 | -1,933,476 | -1,868,665 | -1,815,236 | -1,766,839 |
| Other shareholders' equity | 504 | 734 | 192 | 358 | 146 |
| TOTAL | $145,950 | $178,512 | $239,980 | $288,867 | $93,110 |
| Total Liabilities And Equity | $298,420 | $321,123 | $373,356 | $417,219 | $229,429 |